IL10 and rheumatoid arthritis: In healthy controls, instead, the percentages of IL-10+ B cells following collagen epitope stimulation slightly increased [30], highlighting the fact that studying the effects of tofacitinib in healthy controls does not necessarily stand for RA patients.